UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C. 20549

                                 Form 10-QSB


             [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF
                     THE SECURITIES EXCHANGE ACT OF 1934

                For the quarterly period ended January 31, 2009

                                      OR

          [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF
                     THE EXCHANGE ACT

           For the transition period from _________ to __________

                     Commission file number: 333-127915

                             VITAL PRODUCTS, INC.

   (Exact name of small business issuer as specified in its charter)


            Delaware                                   98-0464272
      ----------------------                         --------------
   (State or other jurisdiction of                 (IRS Employer
     incorporation or organization)               Identification No.)

          245 DRUMLIN CIRCLE, CONCORD ONTARIO, CANADA L4K 3E4
                  (Address of principal executive offices)

                                (905) 482-0200
                           (Issuer's telephone number)

Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes [X]
No [ ]

Indicate by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

As of March 18, 2009, the Issuer had 64,250,000 shares of common stock issued
and outstanding, par value $0.0001 per share.

Transitional Small Business Disclosure Format (Check one): Yes [ ] No [X]


<PAGE>


                          VITAL PRODUCTS, INC
                    QUARTERLY REPORT ON FORM 10-QSB
                FOR THE QUARTER ENDED JANUARY 31, 2009



TABLE OF CONTENTS
                                                                          Page

PART I - FINANCIAL INFORMATION

Item 1 - Financial Statements: Index..........................................3

Balance Sheets as at January 31, 2009 (unaudited) and
   July 31, 2008............................................................ F1

Statements of Operations for the three and six months ended
   January 31, 2009 and 2008 (unaudited).................................... F2

Statement of Shareholders' Deficit for the six months
   ended January 31, 2009 (unaudited)....................................... F3

Statements of Cash Flows for the six months ended
   January 31, 2009 and 2008 (unaudited).................................... F4

NOTES TO FINANCIAL STATEMENTS.............................................F5-F8


Item 2 - Management's Discussion and Analysis or Plan of Operation............4

Item 3 - Controls and Procedures .............................................8


PART II - OTHER INFORMATION

Item 1 - Legal Proceedings....................................................8

Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds..........8

Item 3 - Defaults Upon Senior Securities......................................9

Item 4 - Submission of Matters to a Vote of Security Holders..................9

Item 5 - Other Information ...................................................9

Item 6 - Exhibits ............................................................9


<PAGE>



PART I - FINANCIAL INFORMATION


Item 1. Financial Statements.



VITAL PRODUCTS, INC.

Financial Statements

January 31, 2009 and 2008  (Unaudited)


                                                                           Page


Index of Financial Statements:

Balance Sheets as at January 31, 2009 (unaudited) and
   July 31, 2008............................................................ F1

Statements of Operations for the three and six months ended
   January 31, 2009 and 2008 (unaudited).................................... F2

Statement of Shareholders' Deficit for the six months
   ended January 31, 2009 (unaudited)....................................... F3

Statements of Cash Flows for the six months ended
   January 31, 2009 and 2008 (unaudited).................................... F4

NOTES TO FINANCIAL STATEMENTS.............................................F5-F8

<PAGE>




VITAL PRODUCTS, INC.
Balance Sheets
January 31, 2009 (Unaudited) and July 31, 2008

                                                   January 31,        July 31,
                                                       2009            2008
                                                    ----------      ----------
                                                   (Unaudited)

ASSETS
    Current assets
        Cash                                     $       5,106    $      2,802
                                                    ----------      ----------
               Total current assets                      5,106           2,802
                                                    ----------      ----------
    Other
        Equipment, net of accumulated depreciation      25,593          35,156
                                                    ----------      ----------
                                                        25,593          35,156
                                                    ----------      ----------
Total assets                                      $     30,699    $     37,958
                                                    ==========      ==========

LIABILITIES AND STOCKHOLDERS' EQUITY
    Current liabilities
        Accounts payable and accrued liabilities  $     89,866    $     97,600
        Advances from related parties                    7,312               -
        Note payable to Cellular Connection Ltd.        78,833               -
        Advances from Metro One Development, Inc.      231,429         292,083
        Notes payable to Metro One Development, Inc.         -       1,766,210
                                                    ----------      ----------
Total current liabilities                              407,440       2,155,893
                                                    ----------      ----------

STOCKHOLDERS' DEFICIT
    Capital stock                                        6,425           1,075
    Additional paid-in capital                       4,383,625         334,475
    Stock paid on pending acquisition               (2,000,000)              -
    Prepaid expenses paid with stock                    (8,890)              -
    Accumulated other comprehensive income (loss)      163,630        (176,598)
    Accumulated deficit                             (2,921,531)     (2,276,887)
                                                    ----------      ----------
    Total stockholders' deficit                       (376,741)     (2,117,935)
                                                    ----------      ----------
Total liabilities and stockholders' deficit        $    30,699     $    37,958
                                                    ==========      ==========

See Accompanying Notes to Financial Statements
                                                                             F1
<PAGE>




VITAL PRODUCTS, INC.
Statements of Operations
For the three and six months ended January 31, 2009 and 2008
(Unaudited)

                                For The     For The         For The     For The
                                  Three       Three             Six         Six
                                 Months      Months          Months      Months
                                  Ended       Ended           Ended       Ended
                                January     January         January     January
                               31, 2009    31, 2008        31, 2009    31, 2008
                            -----------  ----------     -----------  ----------
                            (Unaudited) (Unaudited)     (Unaudited) (Unaudited)


Sales                      $         -  $    8,376     $         -  $   15,251
Cost of sales                        -       3,409               -       8,074
                           -----------  ----------     -----------  ----------
Gross profit                         -       4,967               -       7,177
                           -----------  ----------     -----------  ----------
Operating expenses
  Depreciation                   1,816       3,506           3,857       7,011
  Selling, general and
  administrative expenses       54,358      23,112         166,125      41,149
                           -----------  ----------     -----------  ----------
    Total operating expenses    56,174      26,618         169,982      48,160
                           -----------  ----------     -----------  ----------
Net operating loss             (56,174)    (21,651)       (169,982)    (40,983)

Other income (expense)
  Financing costs              (91,319)    (73,993)       (187,835)   (147,585)
  Gain (loss) on currency
  exchange rate                 15,390     (90,815)       (286,827)     91,703
                           -----------  ----------     -----------  ----------
Net income (loss) for the
  period                   $  (132,103) $ (186,459)    $  (644,644) $  (96,865)
                           ===========  ==========     ===========  ==========
Net income (loss) per
  common share, basic
    and fully diluted      $     (0.01) $    (0.02)    $     (0.02) $    (0.01)
                           ===========  ==========     ===========  ==========
Weighted average number
  of common shares
    outstanding             44,993,480  10,750,000      30,555,978  10,750,000
                           ===========  ==========     ===========  ==========




See Accompanying Notes to Financial Statements

                                                                             F2
<PAGE>





VITAL PRODUCTS, INC.
Statement of Changes in Stockholders' Deficit
For the six months ended January 31, 2009
(Unaudited)

<TABLE>
<CAPTION>

                                                           Stock               Accumulated
                                                           Paid On    Prepaid     Other
                                    Additional             Related    Expense    Compreh-
                    Common Stock     Paid-In               Acquisi-    Paid       ensive
                   Number   Amount   Capital     Deficit    tion       With       Income       Total
                                                                       Stock      (Loss)
------------------------------------------------------------------------------------------------------
<S>           <C>         <C>     <C>         <C>        <C>          <C>       <C>        <C>

Balance,
July 31, 2008  10,750,000  $ 1,075 $  334,475 ($2,276,887)        -    $      -  ($176,598)($2,117,935)

Issuance of
stock for
consulting
services          500,000       50     99,950           -         -           -          -     100,000

Issuance of
stock for
conversion of
promissory
note           43,000,000    4,300  1,950,200           -         -      (8,890)         -   1,945,610

Issuance of
stock for
consulting
services       10,000,000    1,000  1,999,000           - (2,000,000)         -          -           -

Foreign
currency
translation             -        -          -           -          -          -    340,228     340,228
Net loss for
  the period            -        -          -    (644,644)         -          -          -    (644,644)
------------------------------------------------------------------------------------------------------
Balance,
Jan. 31, 2009  64,250,000  $ 6,425 $4,383,625 ($2,921,531)(2,000,000)    (8,890)  $163,630 ($  376,741)
======================================================================================================

</TABLE>


See Accompanying Notes to Financial Statements
                                                                             F3
<PAGE>



VITAL PRODUCTS, INC.
Statements of Cash Flows
For the six months ended January 31, 2009 and 2008
(Unaudited)



                                                         For The      For The
                                                          Six          Six
                                                          Months       Months
                                                          Ended        Ended
                                                         January      January
                                                         31, 2009     31, 2008
                                                       -----------  ----------
                                                       (Unaudited)  (Unaudited)


Operating activities
    Net income (loss)                                  $  (644,644)   $(96,865)
    Adjustments to reconcile net loss to net cash used
        by operating activities:
          Gain on currency exchange rate                   286,827     (91,703)
          Depreciation                                       3,857       7,011
          Interest on notes payables                       176,620     147,585
            Stock based expenses                           100,000           -
          Change operating assets and liabilities:
             Accounts receivable                                 -      (4,841)
             Inventory                                           -       4,225
             Accounts payable and accrued liabilities       (9,381)     34,941
                                                       -----------  ----------
Net cash provided by operating activities                  (86,721)        353
                                                       -----------  ----------
Financing activities
   Advance from bank overdraft                                   -           -
   Payment on advances                                     (11,574)          -
   Proceeds from advances                                    7,312       3,004
   Proceeds from Note from Cellular                         78,833           -
                                                       -----------  ----------
Net cash provided by financing activities                   74,571       3,004
                                                       -----------  ----------
Foreign currency translation effect                         14,454      (2,773)
                                                       -----------  ----------
Net increase in cash                                         2,304         584
Cash at beginning of period                                  2,802       2,599
                                                       -----------  ----------
Cash at end of period                                    $   5,106    $  3,183
                                                       ===========  ==========




See Accompanying Notes to Financial Statements
                                                                            F4
<PAGE>

VITAL PRODUCTS, INC.
Notes to Financial Statements
January 31, 2009 and 2008
(Unaudited)

1. NATURE OF OPERATIONS AND BASIS FOR PRESENTATION

Vital Products, Inc. (the "Company") was incorporated in the State of Delaware
on May 27, 2005. On July 5, 2005, the Company purchased the Childcare Division
of Metro One Development, Inc., (formerly On The Go Healthcare, Inc.), which
manufactured and distributed infant care products.  As of July 31, 2008, the
Company's sole business was to manufacture two products under the On The Go
name: a padded training seat and a baby bath.  As of July 31, 2008, these
two products did not produce enough revenue for the Company to cover its
expenses.  After evaluating the market for baby care products, the Company
determined not to invest further funds developing its baby products line.

In September 2008, the Company changed its business plan to pursue a new
line of business as a developer and distributor of industrial packaging
products. The Company is in the very early stage of this change in business
model and further growth will depend on the Company's ability to raise
capital.

The accompanying unaudited financial statements have been prepared in
accordance with the Securities and Exchange Commission requirements for interim
financial statements. Therefore, they do not include all of the information and
footnotes required by accounting principles generally accepted in the United
States for complete financial statements. The financial statements should be
read in conjunction with the annual financial statements for the year ended
July 31, 2008 of Vital Products, Inc.

The interim financial statements present the balance sheet, statements of
operations, shareholders' equity and cash flows of Vital Products, Inc. The
financial statements have been prepared in accordance with accounting
principles generally accepted in the United States.

The interim financial information is unaudited. In the opinion of management,
all adjustments necessary to present fairly the financial position as of
January 31, 2009 and the results of operations, shareholders' equity and cash
flows presented herein have been included in the financial statements. All such
adjustments are the normal and recurring nature.  Interim results are not
necessarily indicative of results of operations for the full year.

2. SIGNIFICANT ACCOUNTING POLICIES

Liquidity and Going Concern

During the six months ended January 31, 2009 and 2008, the Company incurred
income (losses) of ($644,644) and ($96,865), respectively, and cash provided
by (used in) operations was ($86,721) and $353, respectively.  The Company
financed its operations through loans payable and vendors' credit.

Management believes that the current cash balances at January 31, 2009 and net
cash proceeds from operations will not be sufficient to meet their cash
requirements for the next twelve months.

Accordingly, these financial statements have been prepared on a going concern
basis and do not include any adjustments to the measurement and classification
of the recorded asset amounts and classification of liabilities that might be
necessary should the Company be unable to continue as a going concern.  The
Company has experienced losses in the period and has negative working capital.
The Company's ability to realize its assets and discharge its liabilities in
the normal course of business is dependent upon continued support.  The Company
is currently attempting to obtain additional financing from its existing
shareholders and other strategic investors to continue its operations.
However, the Company may not obtain sufficient additional funds from these
sources.
                                                                             F5
<PAGE>

These conditions cause substantial doubt about the Company's ability to
continue as a going concern.  A failure to continue as a going concern would
require that stated amounts of assets and liabilities be reflected on a
liquidation basis that could differ from the going concern basis.

3. SIGNIFICANT ACCOUNTING POLICIES (continued)

Accounting Principles

The Company's accounting and reporting policies conform to generally accepted
accounting principles and industry practice in the United States.  The
financial statements are prepared in United States dollars.


Use of Estimates

The preparation of financial statements in conformity with United States
generally accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the
financial statements and the reported amounts of revenues and expenses during
the year.  Actual results could differ from those estimates.


Foreign Currency Translation

The Company considers the functional currency to be the local currency and,
accordingly, their financial information is translated into U.S. dollars using
exchange rates in effect at year-end. The Canadian dollar is the local
currency. Adjustments resulting from translation of foreign exchange are
included as a component of other comprehensive income (loss) within
stockholders' deficit.


Revenue Recognition

The Company recognizes revenue in accordance with Securities and Exchange
Commission Staff Accounting Bulletin No. 101, "Revenue Recognition in Financial
Statements" ("SAB 101") as modified by Securities and Exchange Commission Staff
Accounting Bulletin No. 104. Under SAB 101, revenue is recognized at the point
of passage to the customer of title and risk of loss, there is persuasive
evidence of an arrangement, the sales price is determinable, and collection of
the resulting receivable is reasonably assured. The Company generally
recognizes revenue at the time of delivery of goods. Sales are reflected net of
discounts and returns.


Allowance for doubtful accounts

The Company records an allowance for doubtful accounts as a best estimate of
the amount of probable credit losses in its accounts receivable.  Each month,
the Company reviews this allowance and considers factors such as customer
credit, past transaction history with the customer and changes in customer
payment terms when determining whether the collection of a receivable is
reasonably assured.  Past due balances over 90 days and over a specified
amount are reviewed individually for collectability.  Receivables are charged
off against the allowance for doubtful accounts when it becomes probable that
a receivable will not be recovered.
                                                                             F6
<PAGE>

3. SIGNIFICANT ACCOUNTING POLICIES (continued)

Inventory

Inventory comprises finished goods held for sale and is stated at lower of
cost or market value.  Cost is determined by the average cost method.  The
Company estimates the realizable value of inventory based on assumptions
about forecasted demand, market conditions and obsolescence.  If the
estimated realizable value is less than cost, the inventory value is
reduced to its estimated realizable value.  If estimates regarding demand
and market conditions are inaccurate or unexpected changes in technology
affect demand, the Company could be exposed to losses in excess of amounts
recorded.


Income Taxes

The Company follows SFAS 109 "Accounting for Income Taxes" for recording the
provision for income taxes. Deferred tax assets and liabilities are computed
based upon the difference between the financial statement and income tax
basis of assets and liabilities using the enacted marginal tax rate applicable
when the related asset or liability is expected to be realized or settled.
Deferred income tax expenses or benefits are based on the changes in the
asset or liability each period. If available evidence suggests that it is
more likely than not that some portion or all of the deferred tax assets will
not be realized, a valuation allowance is required to reduce the deferred tax
assets to the amount that is more likely than not to be realized. Future
changes in such valuation allowance are included in the provision for deferred
income taxes in the period of change.

Basic Loss Per Share

Statement of Financial Accounting Standards No. 128, Earnings Per Share,
(SFAS 128) provides for the calculation of "Basic" and "Diluted" earnings per
share. Basic earnings per share includes no dilution and is computed by
dividing net loss available to common shareholders by the weighted average
number of common shares outstanding for the period. All potentially dilutive
securities have been excluded from the computations since they would be
antidilutive. However, these dilutive securities could potentially dilute
earnings per share in the future.


Comprehensive Income

The Company has adopted Statement of Financial Accounting Standards No. 130
("SFAS 130"), "Reporting Comprehensive Income," which establishes standards
for reporting and display of comprehensive income, its components and
accumulated balances.  Comprehensive income is defined to include all changes
in equity except those resulting from investments by owners or distributions
to owners.  Among other disclosures, SFAS No. 130 requires that all items that
are required to be recognized under the current accounting standards as a
component of comprehensive income be reported in a financial statement that is
displayed with the same prominence as other financial statements.
Comprehensive income is displayed in the statement of shareholders' deficit and
in the balance sheet as a component of shareholders' deficit.

                                                                             F7
<PAGE>

3. SIGNIFICANT ACCOUNTING POLICIES (continued)

New Accounting Pronouncements

In December 2007, the FASB issued SFAS No. 160 "Noncontrolling Interests in
Consolidated Financial Statements - an amendment of ARB No. 51" ("SFAS 160").
SFAS 160 establishes accounting and reporting standards for ownership interests
in subsidiaries held by parties other than the parent, the amount of
consolidated net income attributable to the parent and to the noncontrolling
interest, changes in a parent's ownership interest and the valuation of
retained noncontrolling equity investments when a subsidiary is deconsolidated.
The Statement also establishes reporting requirements that provide sufficient
disclosures that clearly identify and distinguish between the interest of the
parent and the interest of the noncontrolling owners. SFAS 160 is effective for
fiscal years beginning after December 15, 2008. The Company does not expect the
adoption of SFAS 160 to have any impact on its financial position, results of
operation or cash flows.


In May 2008, the FASB issued SFAS No. 162, "The Hierarchy of Generally Accepted
Accounting Principles". SFAS 162 identifies the sources of accounting
principles and the framework for selecting the principles to be used in the
preparation of financial statements of nongovernmental entities that are
presented in conformity with generally accepted accounting principles in the
United States. It is effective 60 days following the SEC's approval of the
Public Company Accounting Oversight Board amendments to AU Section 411, "The
Meaning of Present Fairly in Conformity With Generally Accepted Accounting
Principles". The Company is currently evaluating the impact of SFAS No. 162 on
its financial statements, and the adoption of this statement is not expected to
have a material effect on the Company's financial statements.


4. NOTE PAYABLE TO CELLULAR CONNECTIONS LTD.

The $76,333 advance from Cellular Connection, Ltd. was a result of a
convertible secured promissory note with a face amount of $120,000 issued to
Cellular Connection Ltd. on January 20, 2009 which include one year of interest
totaling $20,000 and actual loan amount totaling $100,000.  The convertible
secured promissory note accrues interest at a rate of 20% per year and has a
maturity date of January 19, 2010.  The outstanding face amount of the
convertible secured promissory note shall increase by 20% on January 19, 2011,
by another 20% on January 19, 2012 and again on each one year anniversary of
January 19, 2012 until it has been paid in full.  The note entitles the note
holder to convert the note, plus accrued interest, anytime prior to the
maturity date, at 75% of the average of the lowest closing bid price during
the fifteen (15) trading days immediately preceding the conversion date.
The note has been accounted for as an original issue discount note due to
the conversion feature.  The discount totaling $40,000 shall be accreted
over the life of the note for a total accreted value of $160,000.
Furthermore, the $20,000 interest which has been included as part of the
overall face amount of the note shall also be accreted over a one year
period.  As of January 31, 2009, the total accretion of both discount and
interest totaled $2,500.  The remaining portion of the note not advanced
totaling $23,667 was received by the Company in February 2009.

Pursuant to the terms of the convertible secured promissory note, Cellular
Connection Ltd. may elect to secure a portion of our assets not to
exceed 200% of the face amount of the note, including, but not limited to,
accounts receivable, cash, marketable securities, equipment, building,
land or inventory.

                                                                             F8
<PAGE>

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

INTRODUCTION

The following discussion and analysis of financial condition and results of
operations is based upon, and should be read in conjunction with our audited
financial statements and related notes thereto included elsewhere in this
report, and in our Form 10-KSB filed November 13, 2008, for the year ended July
31, 2008.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This report contains "forward-looking statements" that involve risks and
uncertainties. You should not place undue reliance on these forward-looking
statements. Our actual results could differ materially from those anticipated
in the forward-looking statements for many reasons, including the risks
described in our Form 10-KSB filed November 13, 2008, for the year ended
July 31, 2008 and our other filings we make with the Securities and Exchange
Commission.  Although we believe the expectations reflected in the
forward-looking statements are reasonable, they relate only to events as of
the date on which the statements are made. We do not intend to update any of
the forward-looking statements after the date of this report to conform these
statements to actual results or to changes in our expectations, except as
required by law.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

The preparation of financial statements and related disclosures in conformity
with accounting principles generally accepted in the United States requires
management to make estimates and assumptions that affect the amounts reported
in the Financial Statements and accompanying notes. Estimates are used for,
but not limited to, the accounting for the allowance for doubtful accounts,
inventories, impairment of long-term assets, income taxes and loss
contingencies. Management bases its estimates on historical experience and on
various other assumptions that are believed to be reasonable under the
circumstances. Actual results could differ from these estimates under different
assumptions or conditions.

We believe the following critical accounting policies, among others, may be
impacted significantly by judgment, assumptions and estimates used in the
preparation of the Financial Statements:

Revenue and expense recognition - We recognize revenue in accordance with
Securities and Exchange Commission Staff Accounting Bulletin No. 101, "Revenue
Recognition in Financial Statements," or SAB 101 as modified by Securities and
Exchange Commission Staff Accounting Bulletin No. 104. Under SAB 101, revenue
is recognized at the point of passage to the customer of title and risk of
loss, there is persuasive evidence of an arrangement, the sales price is
determinable, and collection of the resulting receivable is reasonably
assured. We generally recognize revenue at the time of delivery of goods.
Sales are reflected net of discounts and estimated returns based on
historical patterns.  We record amounts billed to customers for shipping and
handling as sales revenues.  We include costs incurred for shipping and
handling in cost of sales.

We assess the recoverability of long-lived assets whenever events or changes
in business circumstances indicate that the carrying value of an asset may
not be recoverable. An impairment loss is recognized when the sum of the
expected undiscounted future net cash flows over the remaining useful life
is less than the carrying amount of the assets.

                                        4
<PAGE>

OUR BUSINESS

As of July 31, 2008, our sole business was to manufacture two products under
the On The Go name: a padded training seat that helps toddlers with potty
training, and a baby bath with a contoured shape to cradle babies 0-6 months
old.  As of July 31, 2008, these two products failed to produce enough revenue
for us to cover our expenses.  After evaluating the market for baby care
products, we determined that the industry does not offer enough opportunity
for a small company to create products that are affordable to develop, price
competitive for the consumer and that we can introduce into distribution
channels without significant expense.  As a result, we decided not to
invest further funds developing our baby products line.

In August 2008, we began the process of developing a new line of business as a
distributor of industrial packaging products. On September 17, 2008, we entered
into a Letter of Intent to purchase Montreal-based Den Packaging Corporation.
We believe that the addition of Den Packaging Corporation will undoubtedly
strengthen our standing in the industrial packaging sector.

On October 7, 2008, we entered into a consulting agreement with DLW Partners of
Toronto, an industrial packaging consulting firm specializing in market
analysis, market and product strategies and the development of product line
extensions.  We believe that DLW will work closely with us to develop new
products for existing markets and establish product line extensions to further
our market share. Most importantly DLW has experience in the development of
environmentally friendly products and we expect that DLW will further our
initiative to develop environmentally acceptable products.

On October 21, 2008, we entered into a sales and marketing agreement with Eco
Tech Development LLC of Nevada, a product research and development company
specializing in eco-friendly industrial packaging applications, whereby we
will market certain proprietary and patent-pending technologies that have
recently been developed by Eco Tech, beginning with the marketing of a new
bio-based foam packaging product.

During the month on December 2008, we met with three global manufacturers and
one North American company to present our new bio-based foam technology to
their marketing and technical groups. The discussions with each company
included individual market share, technical service abilities, number of sales
people, expected growth projections with regards to total market value and
the time frame required for each company to convert their current business
over to our bio-based foam.

On January 13, 2009, we formally announced that we had commenced production
of Biofill(TM), our bio-based foam in place packaging product, and on
January 26, 2009 we received our first purchase order.  On January 30, 2009
we received a second purchase order for our Biofill(TM) product from a major
North American manufacturer.

On February 19, 2009, we signed an agreement to market a new paper packaging
system.  While paper packaging has been a staple in the industrial packaging
market for many years, our new system produces a craft paper product that
simulates a moldable nest.  We believe this product is price competitive
with other paper products and gives us the advantage of performance and range
of use.  Although our new line of business continues to develop, we believe
that these purchase orders certainly validate our product and reflect the
industrial packaging industry's trend towards environmentally friendly
product lines.

                                        5
<PAGE>

RESULTS OF OPERATIONS

COMPARISON OF RESULTS FOR THE SIX MONTHS ENDED JANUARY 31, 2009 AND 2008

Revenues: We did not record any revenues for the six months ended
January 31, 2009, as compared to revenues of $15,251 for the six months ended
January 31, 2008.  The decrease in revenues was primarily the result of our
entering a new product line.

Cost of Sales: Our cost of sales for the six months ended January 31, 2009
was $0, compared to $8,074 for the six months ended January 31, 2008.
The decrease in cost of sales was directly related to the decrease in sales.

Selling, General and Administrative Expenses: Our selling, general and
administrative costs were $166,125 for the six months ended January 31, 2009,
compared to $41,149 for the six months ended January 31, 2008. The increase
in selling, general and administrative expenses was primarily the result of
stock based expenses related to consulting services.

Net loss: Our net loss for the six months ended January 31, 2009 was $644,644,
compared to a net loss of $96,865 for the six months ended January 31, 2008.
The increase in net loss was a result of the previous reasons mentioned above.

Total Assets: Our total assets as of January 31, 2009 were $30,699, a
decrease of $7,259, as compared to the fiscal year ended July 31, 2008
which were $37,958.  The decrease was a result of the depreciation of our
equipment over the six month period. Our total liabilities as of
January 31, 2009 were $407,440, a decrease of $1,748,453, as compared to
$2,155,893 for the fiscal year ended July 31, 2008. The decrease in our
total liabilities compared to the prior year ended July 31, 2008 was primarily
the result of the payment on our note payable to Metro One Development, Inc.
(formerly On The Go Healthcare, Inc.) with common stock.

OFF-BALANCE SHEET ARRANGEMENTS

As of January 31, 2009, we did not have any off-balance sheet arrangements.

LIQUIDITY AND CAPITAL RESOURCES

As of January 31, 2009, we had total current assets of $5,106 and total current
liabilities of $407,440, resulting in a working capital deficit of $402,334.
As of that date, we had cash of $5,106. Our cash flow from operating activities
for the six months ended January 31, 2009 resulted in a deficit of $86,721. Our
current cash balance and cash flow from operating activities will not be
sufficient to fund our operations. Our cash flow from financing activities for
the six months ended January 31, 2009 resulted in a surplus of $74,571. We
believe we will need to raise capital of approximately $300,000 to $350,000
through either debt or equity instruments to fund our operations for the next
12 months. However, we may not be successful in raising the necessary capital
to fund our operations. In addition to the amounts needed to fund our
operations, we may need to generate an additional $500,000 to cover our current
liabilities for the next 12 months.

As of January 31, 2009, we have $7,312 in advances from related parties,
$78,833 of advances due from Cellular Connection Ltd. and $231,429 of advances
due to Metro One Development, Inc. (formerly On The Go Healthcare, Inc.),
payable on demand.

                                        6
<PAGE>

The $76,333 advance from Cellular Connection, Ltd. was a result of a
convertible secured promissory note with a face amount of $120,000 issued
to Cellular Connection Ltd. on January 20, 2009 which include one year of
interest totaling $20,000 and actual loan amount totaling $100,000.  The
convertible secured promissory note accrues interest at a rate of 20% per
year and has a maturity date of January 19, 2010.  The outstanding face
amount of the convertible secured promissory note shall increase by 20% on
January 19, 2011, by another 20% on January 19, 2012 and again on each one
year anniversary of January 19, 2012 until it has been paid in full.  The
note entitles the note holder to convert the note, plus accrued interest,
anytime prior to the maturity date, at 75% of the average of the lowest
closing bid price during the fifteen (15) trading days immediately
preceding the conversion date.  The note has been accounted for as an
original issue discount note due to the conversion feature.  The discount
totaling $40,000 shall be accreted over the life of the note for a total
accreted value of $160,000.  Furthermore, the $20,000 interest which has
been included as part of the overall face amount of the note shall also
be accreted over a one year period.  As of January 31, 2009, the total
accretion of both discount and interest totaled $2,500.  The remaining
portion of the note not advanced totaling $23,667 was received by the
Company in February 2009.

Pursuant to the terms of the convertible secured promissory note, Cellular
Connection Ltd. may elect to secure a portion of our assets not to
exceed 200% of the face amount of the note, including, but not limited
to, accounts receivable, cash, marketable securities, equipment, building,
land or inventory.

Until we are able to generate positive cash flows from operations in an amount
sufficient to cover our current liabilities and debt obligations as they become
due, if ever, we will remain reliant on borrowing funds or selling equity. We
intend to raise funds through the issuance of debt or equity. Raising funds in
this manner typically requires much time and effort to find accredited
investors, and the terms of such an investment must be negotiated for each
investment made. There is a risk that such additional financing may not be
available, or may not be available on acceptable terms, and the inability to
obtain additional financing or generate sufficient cash from operations could
require us to reduce or eliminate expenditures for capital equipment,
production, design or marketing of our products, or otherwise curtail or
discontinue our operations, which could have a material adverse effect on our
business, financial condition and results of operations.
We may not be able to raise sufficient funds to meet our obligations. If we do
not raise sufficient funds, our operations will be curtailed or will cease
entirely and you may lose all of your investment.

An optional source of financing may be through the sale of equity.  However,
this source of financing may not be available to us and demand for our
equity/debt instruments may not be sufficient to meet our capital needs and
financing may not be available on terms favorable to us.

To the extent that we raise capital through the sale of equity or convertible
debt securities, the issuance of such securities may result in dilution to
existing stockholders.  If additional funds are raised through issuance of debt
securities, these securities may have rights, preferences and privileges senior
to holders of common stock and the terms of such debt could impose restrictions
on our operations.  Regardless of whether our cash assets prove to be adequate
to meet our operational needs, we may seek to compensate providers of services
by issuance of our stock in lieu of cash, which may also result in dilution
to existing stockholders.

                                        7
<PAGE>


ITEM 3. CONTROLS AND PROCEDURES.

Disclosure Controls and Procedures

Our management evaluated, with the participation of our Chief Executive Officer
and our Chief Financial Officer, the effectiveness of our disclosure controls
and procedures as of the end of the period covered by this quarterly report on
Form 10-QSB.  Based on this evaluation, our Chief Executive Officer and our
Chief Financial Officer have concluded that our disclosure controls and
procedures are effective to ensure that information we are required to disclose
in reports that we file or submit under the Securities Exchange Act of 1934
(i) is recorded, processed, summarized and reported within the time periods
specified in Securities and Exchange Commission rules and forms, and (ii) is
accumulated and communicated to our management, including our Chief Executive
Officer and our Chief Financial Officer, as appropriate to allow timely
decisions regarding required disclosure.  Our disclosure controls and
procedures are designed to provide reasonable assurance that such information
is accumulated and communicated to our management.  Our disclosure controls and
procedures include components of our internal control over financial reporting.
Management's assessment of the effectiveness of our internal control over
financial reporting is expressed at the level of reasonable assurance that the
control system, no matter how well designed and operated, can provide only
reasonable, but not absolute, assurance that the control system's objectives
will be met.

Changes in Internal Controls over Financial Reporting

There were no changes in our internal control over financial reporting that
occurred during our last fiscal quarter that have materially affected, or are
reasonably likely to materially affect, our internal control over financial
reporting.


                              PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

We may be involved from time to time in ordinary litigation, negotiation and
settlement matters that will not have a material effect on our operations or
finances. We are not aware of any pending or threatened litigation against our
Company or our officers and directors in their capacity as such that could have
a material impact on our operations or finances.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

On October 2, 2008, we issued 500,000 shares of common stock to Downshire at a
price of $0.20 per share.

On October 2, 2008, we issued 10,000,000 shares of common stock to Michael
Levine at a price of $0.20.  Mr. Levine is our Chief Executive Officer.

During the period between October 14, 2008 and October 24, 2008, Metro One
Development, Inc. converted $1,708,480 in principal and accrued interest
under a promissory note into 15,200,000 shares of our common stock, at a
conversion price of $0.1125 per share.

On December 8, 2008, Metro One Development, Inc. converted $37,500 in interest
accrued under a promissory note into 1,000,000 shares of our common stock, at
a conversion price of $0.0375 per share.

On December 22, 2008, Metro One Development, Inc. converted $12,000 in interest
accrued under a promissory note into 800,000 shares of our common stock, at
a conversion price of $0.0150 per share.

                                        8
<PAGE>

During the period between December 29, 2008 and January 9, 2009, Metro One
Development, Inc. converted $195,000 in interest accrued under a promissory
note into an aggregate of 26,000,000 shares of our common stock, all at a
conversion price of $0.0075 per share.

With respect to the issuance of our securities as described above, we relied
on the Section 4(2) exemption from securities registration under the federal
securities laws for transactions not involving a public offering. No
advertising or general solicitation was employed in the offering of the
securities. The securities were sold to accredited investors. The securities
were offered for investment purposes only and not for the purpose of resale
or distribution and the transfer thereof was appropriately restricted by us.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

In the three months ended January 31, 2009, we did not submit any matters to
a vote of security holders.

ITEM 5. OTHER INFORMATION.

Not applicable.

ITEM 6. EXHIBITS.

Exhibit Number          Description of Exhibit

3.1   Certificate of Incorporation (included as exhibit 3.1 to the Form SB-2
      filed August 29, 2005 and incorporated herein by reference).

3.2   By-laws (included as exhibit 3.2 to the Form SB-2 filed August 29, 2005
      and incorporated herein by reference).

4.1   Form of Stock Certificate (included as exhibit 4.1 to the Form SB-2
      filed October   26, 2006 and incorporated herein by reference).

10.1  Asset Sale Agreement between the Company and On The Go Healthcare, Inc.
      dated July 5, 2005 (included as exhibit 10.3 to the Form SB-2 filed
      August 29, 2005 and incorporated herein by reference).

10.2  Secured Promissory Note between the Company and On The Go Healthcare,
      Inc. dated February 23, 2006 (included as exhibit 10.2 to the Form SB-2
      filed February 24, 2006 and incorporated herein by reference).

10.3  Secured Promissory Note between the Company and On The Go Healthcare,
      Inc. dated February 23, 2006 (included as exhibit 10.3 to the Form SB-2
      filed February 24, 2006 and incorporated herein by reference).

10.4  Vital Products, Inc. Trust Agreement between the Company and Amy Trombly
      as Trustee dated May 27, 2005 (included as exhibit 10.4 to the Form
      SB-2 filed October 26, 2006 and incorporated herein by reference).

10.5  Secured Promissory Note between the Company and The Cellular Connection
      Ltd. dated January 20, 2009 (filed herewith).

31.1  Certification of Chief Executive Officer pursuant to Section 302 of
      the Sarbanes-Oxley Act of 2002.

31.2  Certification of Chief Financial Officer pursuant to Section 302 of
      the Sarbanes-Oxley Act of 2002.

32.1  Certification of Officers pursuant to 18 U.S.C. Section 1350, as adopted
      pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

                                        9
<PAGE>

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned thereunto
duly authorized.

Dated: March 20, 2009                        Vital Products, Inc.


                                             By:/s/ Michael Levine
                                             --------------------------
                                             Michael Levine
                                             Principal Executive Officer




Dated: March 20, 2009                        By:/s/ Henry Goldberg
                                             ----------------------------
                                             Henry Goldberg, Chief Financial
                                             and Principal Accounting Officer
                                             and Director

                                        10
<PAGE>